Re: Long-Term Survival Outcomes with Intravesical Nanoparticle Albumin-Bound Paclitaxel for Recurrent Non-Muscle-Invasive Bladder Cancer after Previous bacillus Calmette-Guerin Therapy Editorial Comment

被引：0
|
作者：
Chang, Sam S.
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 201卷 / 04期
关键词：
D O I：
10.1097/JU.0000000000000097
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：665 / 665
页数：1
相关论文
共 50 条
  • [31] DIABETES SEVERITY AND METFORMIN ARE ASSOCIATED WITH INTRAVESICAL BACILLUS CALMETTE-GUERIN OUTCOMES IN NON MUSCLE INVASIVE BLADDER CANCER
    Sekar, Rishi R.
    Brisbane, Wayne G.
    Holt, Sarah K.
    Winters, Brian R.
    Yu, Evan Y.
    Gore, John L.
    Wright, Jonathan L.
    Schade, George R.
    JOURNAL OF UROLOGY, 2019, 201 (04): : E229 - E229
  • [32] Validation of Algorithm to Identify Adequate Intravesical Bacillus Calmette-Guerin Therapy in Non-Muscle-Invasive Bladder Cancer Patients in Administrative Claims
    Chuo, Ching-Yi
    Richard, Kyle A.
    Zivkovic, Marko
    Yi, Jingbo
    Pattipaka, Thirupathi
    Derleth, Christina
    Lin, Shih-Wen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 97 - 97
  • [33] Impact of UTUC on Outcomes of Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin
    Bree, K. K.
    Hensley, P. J.
    Brooks, N.
    Matulay, J.
    Navai, N.
    Grossman, H. B.
    Matin, S. F.
    Dinney, C. P.
    Kamat, A. M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 898 - 898
  • [34] Re: Sequential Intravesical Mitomycin plus Bacillus Calmette-Guerin for Non-Muscle-Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial Editorial Comment
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2016, 196 (03): : 688 - 688
  • [35] Phase I trial of intravesical nanoparticle albumin-bound paclitaxel in the treatment of BUG-refractory non-muscle-invasive bladder cancer
    Barlow, L. J.
    Laudano, M. A.
    Mann, A. J.
    Desal, A.
    Petrylak, D. P.
    Benson, A. C.
    McKlernan, J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guerin Therapy
    Kim, Seon-Kyu
    Park, Seong-Hwan
    Kim, Yeong Uk
    Byun, Young Joon
    Piao, Xuan-Mei
    Jeong, Pildu
    Kim, Kyeong
    Lee, Hee Youn
    Seo, Sung Pil
    Kang, Ho Won
    Kim, Won Tae
    Kim, Yong-June
    Lee, Sang-Cheol
    Moon, Sung-Kwon
    Choi, Yung Hyun
    Kim, Wun-Jae
    Kim, Seon-Young
    Yun, Seok Joong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (03) : 1 - 16
  • [37] Is Intravesical Bacillus Calmette-Guerin Therapy Superior to Chemotherapy for Intermediate-risk Non-muscle-invasive Bladder Cancer? - An Ongoing Debate
    Han, Kyung-Sik
    You, Dalsan
    Jeong, In Gab
    Kwon, Teakmin
    Hong, Bumsik
    Hong, Jun Hyuk
    Ahn, Hanjong
    Ahn, Tai Young
    Kim, Choung-Soo
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (03) : 252 - 258
  • [38] A MOLECULAR SIGNATURE DETERMINES THE PROGNOSTIC AND THERAPEUTIC SUBTYPE OF NON-MUSCLE-INVASIVE BLADDER CANCER RESPONSIVE TO INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY
    Kim, Seon-Kyu
    Yun, Seok-Joong
    Kang, Ho Won
    Kim, Kyeong
    Lee, Hee Youn
    Kim, Won Tae
    Kim, Yong-June
    Lee, Sang-Cheol
    Kim, Wun-Jae
    JOURNAL OF UROLOGY, 2021, 206 : E1129 - E1130
  • [39] A Plea for Long-Term Surveillance in Bacillus Calmette-Guerin-Treated Non-Muscle-Invasive Bladder Cancer
    Meijer, Richard P.
    van Rhijn, Bas W. G.
    EUROPEAN UROLOGY, 2012, 61 (03) : 508 - 509
  • [40] Phase II Trial of Intravesical Nanoparticle Albumin Bound Paclitaxel for the Treatment of Nonmuscle Invasive Urothelial Carcinoma of the Bladder after bacillus Calmette-Guerin Treatment Failure
    McKiernan, James M.
    Holder, Dara D.
    Ghandour, Rashed A.
    Barlow, LaMont J.
    Ahn, Jennifer J.
    Kates, Max
    Badalato, Gina M.
    Roychoudhury, Arindam
    Decastro, G. Joel
    Benson, Mitchell C.
    JOURNAL OF UROLOGY, 2014, 192 (06): : 1633 - 1638
12345